W.O.M. World of Medicine AG

EANS-Adhoc: WORLD OF MEDICINE investing more in research & development and sales expansion/ Adjustment to 2009 earnings goal/ Management Board plans to continue share buy-back/

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro   adhoc with the aim of a Europe-wide distribution. The issuer is solely   responsible for the content of this announcement. --------------------------------------------------------------------------------@@end@@

Share buy-back


Medical device manufacturer WORLD OF MEDICINE is stepping up investments in research and development as well as in the expansion of its sales. The objective is to expand the Company's market position and secure its employee's jobs over the medium to long-term, instead of focusing on short term yield targets. For this reason, the Management Board today announced that it is approving the necessary expenditures and adjusting the earnings goal for fiscal year 2009 to a return on sales before taxes of 6%. Originally, 11% was planned. The current sales and cost projection until the end of fiscal year 2009 is the basis for this change.

Moreover, the Management Board with approval of the Supervisory Board, today decided to continue with immediate effect the buy-back of own shares carried out under the management of a bank until November 27, 2010 in case of a renewal of the authorization to buy-back own shares of the General Shareholders' Meeting of W.O.M. WORLD OF MEDICINE AG taking place tomorrow.The average purchase price of the shares may not be more than 10 % above or more than 10 % below the average Xetra Closing Price (or if this authorization is based on the Xetra closing price the closing price determined by a system which may have replaced the Xetra System) at the Frankfurt Exchange in the 5 days preceding the trade.

The Management Board of W.O.M. WORLD OF MEDICINE AG with approval of the Supervisory Board had decided on May 4, 2009 to buy-back own shares on the basis of the authorization of the General Shareholders' Meeting of W.O.M. WORLD OF MEDICINE AG on May 29, 2008. According to the resolution of the Management Board the buyback was limited until May 27, 2009. An independent bank purchased a total of 2,370 shares from May 19 to May 26, 2009 in the total amount of EUR 22,240 (without additional charges). This corresponds to 0.3 % of the share capital. The average price per share reached EUR9.38. The purchase of the shares was conducted by an independent bank at the electronic trading platform of the Frankfurt stock exchange (Xetra). The Company holds own shares equal to 2.94 % of the share capital at the time of the General Shareholders Meeting of May 28, 2009 (EUR9,000,000). In case the buy-back is to be continued the Company, according to legal provisions, may buy-back up to 7.06 % of this share capital. An overview of all transactions of the share buyback is available at www.world- of-medicine.com under 'Investor Relations'.

The Management Board

@@start.t2@@end of announcement                                                 euro adhoc

ots Originaltext: W.O.M. World of Medicine AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Stefanie Gehrke
Cell Phone: + 49 (0) 172 402 67 40
E-Mail: stefanie.gehrke@womcorp.com

Branche: Pharmaceuticals
ISIN:      DE0006637390
WKN:        663739
Index:    CDAX, Prime All Share, Technologie All Share
Börsen:  Frankfurt / regulated dealing/prime standard
              Berlin / free trade
              Hamburg / free trade
              Stuttgart / free trade
              Düsseldorf / free trade
              München / free trade

Weitere Meldungen: W.O.M. World of Medicine AG

Das könnte Sie auch interessieren: